HSBC Holdings’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,757
| Closed | -$167K | – | 2698 |
|
|
2022
Q3 | $167K | Buy |
12,757
+2,432
| +24% | +$31.8K | ﹤0.01% | 2237 |
|
|
2022
Q2 | $132K | Buy |
+10,325
| New | +$132K | ﹤0.01% | 2556 |
|
|
2021
Q2 | – | Sell |
-8,996
| Closed | -$257K | – | 2613 |
|
|
2021
Q1 | $257K | Sell |
8,996
-2,306
| -20% | -$65.9K | ﹤0.01% | 2045 |
|
|
2020
Q4 | $340K | Sell |
11,302
-4,045
| -26% | -$122K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $248K | Buy |
15,347
+4,591
| +43% | +$74.2K | ﹤0.01% | 1934 |
|
|
2020
Q2 | $212K | Hold |
10,756
| – | – | ﹤0.01% | 1949 |
|
|
2020
Q1 | $135K | Buy |
10,756
+385
| +4% | +$4.83K | ﹤0.01% | 2000 |
|
|
2019
Q4 | $190K | Sell |
10,371
-15,865
| -60% | -$291K | ﹤0.01% | 2286 |
|
|
2019
Q3 | $363K | Buy |
+26,236
| New | +$363K | ﹤0.01% | 1936 |
|